CytoSorb Therapy in COVID-19 (CTC) Patients Requiring Extracorporeal Membrane Oxygenation: A Multicenter, Retrospective Registry

Introduction: CytoSorb extracorporeal blood purification therapy received FDA Emergency Use Authorization (EUA) to suppress hyperinflammation in critically ill COVID-19 patients. The multicenter CTC Registry was established to systematically collect patient-level data, outcomes, and utilization patt...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Tae, Hayanga, Jeremiah, Durham, Lucian, Garrison, Lawrence, McCarthy, Paul, Barksdale, Andy, Smith, Deane, Bartlett, Robert, Jaros, Mark, Nelson, Peter, Molnar, Zsolt, Deliargyris, Efthymios, Moazami, Nader
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720923/
https://www.ncbi.nlm.nih.gov/pubmed/34988092
http://dx.doi.org/10.3389/fmed.2021.773461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720923/
https://www.ncbi.nlm.nih.gov/pubmed/34988092
http://dx.doi.org/10.3389/fmed.2021.773461

Ejemplares similares